Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 2/3 1

Status

Completed 23Recruiting 7Terminated 5Unknown 4Active not recruiting 4Withdrawn 3

Sponsor Class

NIH 7OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 3Lymphoid 1

Conditions

Glioblastoma 2Recurrence 1Lymphoma 1Glioma 1Brain Neoplasms 1

Interventions

Cisplatin 349Oxaliplatin 258Capecitabine 257Radiotherapy 238Docetaxel 221Gemcitabine 220Carboplatin 220Cyclophosphamide 215Drug Therapy 214apatinib 199Paclitaxel 198Bevacizumab 192camrelizumab 188Fluorouracil 186sintilimab 131Irinotecan 124Blood Specimen Collection 123Dexamethasone 122Etoposide 118Surgical Procedures, Operative 114Radiosurgery 114toripalimab 113pembrolizumab 108Pemetrexed 108anlotinib 105S 1 (combination) 104Leucovorin 99Surveys and Questionnaires 97tislelizumab 95Doxorubicin 95

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER × Lomustine × Clear all
NCT03025893 2021-04-19

STELLAR

Amsterdam UMC, location VUmc

Phase 2/3 Unknown
100 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT02333513 2015-04-09

A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation

Hebei Yanda Hospital

Phase NA Unknown
100 enrolled
CNS

Glioma

NCT01737346 2012-12-03

Procarbazine and Lomustine in Recurrent Glioblastoma

Incheon St.Mary's Hospital

Phase 2 Unknown
52 enrolled
CNS

Glioblastoma, Recurrence

NCT00989352 2009-10-05

PRIMAIN

University Hospital Freiburg

Phase 2 Unknown
56 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡